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Rapid information dissemination is critical in a world changing rapidly due to global threats. Ubiquitous internet access has 
created new methods of information dissemination that are rapid, far-reaching, and universally accessible. However, inaccur-
acies may accompany rapid information dissemination, and rigorous evaluation of primary data through various forms of peer 
review is crucial. In an era in which high-quality information can save lives, it is critical that infectious diseases specialists are 
well versed in digital strategy to effectively disseminate information to colleagues and the community and diminish voices 
spreading misinformation. In this study, we review how social media can be used for rapid dissemination of quality informa-
tion, benefits and pitfalls of social media use, and general recommendations for developing a digital strategy as an infectious 
diseases specialist. We will describe how the Infectious Diseases Society of America has leveraged digital strategy and social 
media and how individuals can amplify these resources to disseminate information, provide clinical knowledge, community 
guidance, and build their own person brand. We conclude in providing guidance to infectious diseases specialists in aiming to 
build and preserve public trust, consider their audience and specific goals, and use social media to highlight the value of the 
field of infectious diseases.
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At a time when dissemination of in-
formation happens in milliseconds and 
the spread of infectious diseases has 
touched every corner of the world, it 
is critical to evaluate the ways in which 
digital strategies are utilized to share and 
consume information. Evidence-based 
guidance is critical, and inaccurate in-
formation can cause catastrophic loss 
of lives in vulnerable communities. The 
coronavirus disease 2019 (COVID-19) 
pandemic catalyzed the involvement of 
the infectious disease community in ef-
fective digital strategy as societies sought 
reliable, accurate information at a time 
when the lines between expert opinion 
and political ideology were being actively 
blurred. Concerted efforts must be made 
within the profession to streamline high-
quality information and disseminate it 
strategically to reach a wide and diverse 
audience.
In 2018, the Infectious Diseases 
Society of America (IDSA) Board of 
Directors outlined and emphasized the 
society’s strategic plan for the next sev-
eral years [1]. The IDSA identified core 
opportunities for improvement in mar-
keting, communications, expanding 
membership touchpoints, and focusing 
on attracting diverse membership and 
leadership. One of the strategic priorities 
is to advance IDSA’s role as a preeminent 
source of information and knowledge. 
The IDSA established the Digital Strategy 
Advisory Group (DSAG) in 2019  “To 
advise IDSA and its members regarding 
digital strategy, including the use of web, 
email, social media, mobile and other 
digital media and digital channels” [1]. 
In this study, the DSAG will discuss the 
background of digital strategy use in in-
fectious diseases, provide an overview of 
the types of digital strategy used, describe 
the benefits and pitfalls of digital strategy, 
and make recommendations for how we 
can best leverage digital strategy in the 
field of infectious diseases.
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DIGITAL STRATEGY USE IN 
INFECTIOUS DISEASES
Social networking is a basic human in-
stinct. Sharing experiences and skills 
allow humans to form small communi-
ties, but these interactions can be lim-
ited by physical distance, time zones, and 
social boundaries. Social media tran-
scends these limitations, providing free 
access to information across a variety of 
platforms reaching different consumer 
demographics. Social media has become 
a major communication tool in the 21st 
century. Facebook, created in 2004, has 
1.62 billion active daily users. Twitter, 
launched in 2006, has 330 million 
monthly active users with 145 million 
daily active users producing 500 million 
tweets daily [2]. As a result, a significant 
amount of information is now accessed 
largely through online platforms. In sci-
ence, social media has had enormous 
benefits because it allows for the rapid 
dissemination of information and it in-
creases public interaction with experts 
[3]. Digital strategy is a key means to con-
nect people and disseminate information 
in medicine. A digital strategy identifies 
the individual/organization’s specific 
goals, generates content directed to the 
target audience in line with these goals, 
and chooses platforms that aligns with 
the target audience and intended impact 
of the communication. In medicine, the 
target audience can include both health-
care professionals and/or the communi-
ties they serve. For example, a campaign 
designed to teach about the impact of 
COVID-19 spread in young people be-
tween ages of 18–29 could be best dissem-
inated using platforms such as Instagram, 
Snapchat, TikTik, or YouTube, which are 
the social media platforms most utilized 
by that age range [4].
In parallel, digital media has ex-
acerbated information overload and 
widespread dissemination of unvetted, 
low-quality information propagating 
misinformation and highlighting the 
need for consistent and reliable pri-
mary information sources to empower 
and protect consumers of medical 
information. Pandemics are accom-
panied by “infodemics,” or outbreaks of 
misinformation. The rapid generation of 
partial information amidst an urgency 
to develop emerging treatment para-
digms allows for scientific inaccuracies 
and misleading opinions [5]. Some ex-
amples include false claims around the 
origin of severe acute respiratory syn-
drome coronavirus 2 and the role of 
hydroxychloroquine in the treatment of 
COVID-19 [6]. Therefore, professional 
organizations and healthcare profes-
sionals, in the interests of their members/
colleagues and society, “must” engage 
with digital and social media to mitigate 
misinformation and meet the growing 
need for timely, well curated, reliable 
sources of medical knowledge. Doing 
this successfully requires an intentional, 
thoughtful approach. An individual or 
organization’s digital strategy ideally 
should be multifaceted for maximum 
impact. The strategy must consider the 
mission or goal, the audience targeted, 
and be nimble to evaluate and revise ac-
cording to the response. Table 1 summar-
izes main categories of dissemination of 
information through digital strategy and 
examples of effective use of those plat-
forms. The authors have provided a lim-
ited list of examples of digital media that 
is not intended to be comprehensive or an 
endorsement by the IDSA or the authors. 
These include blogs, lay press Op Ed ar-
ticles, social media, video communica-
tion, podcasts, websites and resources 
centers, preprints, visual abstracts and 
infographics, guidelines, and apps. The 
authors strove to balance representation 
of gender, geographic, age, and perspec-
tive in these listings.
The IDSA Social media content 
(Tweets, Facebook posts, LinkedIn posts, 
etc) represents IDSA as an organization, 
but the organization itself is a community 
of more than 12 000 physicians, scientists, 
and public health experts who specialize 
in infectious disease. The mission of IDSA 
is to improve the health of individuals, 
communities, and society by promoting 
excellence in patient care, education, 
research, public health, and prevention 
relating to infectious diseases. The digital 
content is meant to represent and amplify 
that mission. Tweets are written by the 
IDSA digital and communications staff 
in collaboration with different internal 
departments. The IDSA also retweets 
messages from its members and other or-
ganizations. The organization has broad 
and diverse membership, so not every 
member will agree with every message or 
statement that is put out. The IDSA aims 
to present a balanced view, rooted in sci-
ence, and the organization is committed 
to listening to the views and opinions of 
all its members.
In this critical time of a pandemic, 
IDSA has built further infrastructure 
to research, write, and publish informa-
tion about COVID-19. Our COVID-19 
Real Time Learning Network content 
is researched and created by our med-
ical editors, and it goes through mul-
tiple rounds of editing by internal staff 
before being published. Our podcasts, 
media briefings, and Saturday Clinician 
Calls feature IDSA members and other 
COVID-19 subject matter experts. The 
ISDA COVID-19 guidelines are created 
by expert medical guidelines panels and 
supported by medical writers, medical 
editors, and IDSA staff.
BENEFITS OF SOCIAL MEDIA 
USE TO SUPPORT A DIGITAL 
STRATEGY
The IDSA strategic plan had included 
rapid guideline development and revision, 
enhanced member engagement, and de-
velopment of new dissemination/commu-
nication strategies to highlight the value of 
our specialty. The COVID-19 pandemic 
jumpstarted these plans. Figure 1 summar-
izes IDSA’s multifaceted digital strategy 
response, with rapid website updates to in-
corporate a new public facing COVID-19 
resource, expedited development and dis-
semination of clinical guidelines, and web-
based video conferencing technology to 
host expert discussions and question and 
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A major benefit of digital and social 
media in infectious diseases is dissem-
ination of information for patient care, 
medical education, and innovations in 
research, including clinical trial recruit-
ment and published research findings [7]. 
Social media has been used as an educa-
tional tool for (1) antimicrobial steward-
ship for medical and pharmacist trainees 
Table 1. Types of Platforms Used in Digital Strategies for Dissemination of Information in Infectious Diseases
Platform Strengths and Pitfalls Examples
Blogs Specialty writing, generally 
limited audience  
More expeditious publica-
tion than peer-reviewed 
articles, with more re-
laxed writing style  
May need additional social 
media dissemination to 
reach wider audience
Dr. Bobbi Pritt: Creepy Dreadful Wonderful Parasites https://parasitewonders.blogspot.com/  
Dr. Paul Sax: HIV and ID Observations https://blogs.jwatch.org/hiv-id-observations/  
Dr. Boghuma Titanji: The ID Doc http://theiddoc.net/  
IDStewardship: Promoting Clinical Pharmacy & Antimicrobial Stewardship (multiple contributors): https://
www.idstewardship.com/  
Microcosm: the blog of the Diagnostic Bacteriology Laboratory at the Singapore General Hospital 
https://10minus6cosm.tumblr.com  
Controversies in Hospital Infection Prevention (multiple contributors) https://haicontroversies.blogspot.com/  
Science Speaks: Global ID News: https://sciencespeaksblog.org/
Op Ed’s in lay 
press 
Wider audience including 
non-healthcare profes-
sionals, but harder to get 
these pieces accepted
Dr. Peter Hotez (eg, , NYT Jan 2020: https://www.nytimes.com/2020/01/09/opinion/vaccine-hesitancy.html)  
Dr. Matifadza Hlatshwayo Davis (eg, , Newsweek September 2020: https://www.newsweek.com/rushing-
covid-19-vaccine-risks-leaving-behind-people-most-risk-opinion-1530761) 
Social Media Twitter: Microblogging plat-
form with photo/video 
capabilities; Can unite 
multiple groups over a 
single topic using care-
fully curated hashtag  
Instagram: photo sharing 
platform  
Facebook: photos/videos + 
long-form blogging
@IDJClub https://twitter.com/IDJClub  
@ASP_Chat https://twitter.com/asp_chat  
@UNMC_ID https://twitter.com/UNMC_ID  
@SHEAEpi https://twitter.com/SHEA_Epi  
@SIDPharm https://twitter.com/SIDPharm  
@HIVMA https://twitter.com/HIVMA  
@PIDS https://twitter.com/PIDSociety  
@MSG_ERC https://twitter.com/MSG_ERC  
@IPACCanada https://twitter.com/IPACCanada  
ASM https://www.instagram.com/ASMicrobiology/  
WHO https://www.instagram.com/who/?hl=en  
IDSA https://www.instagram.com/idsafoundation/  
Soc Bras de Infectologiaa https://www.instagram.com/sbinfecto/?hl=en  





Each week the one-hour tel-
econference focuses on 
timely issues of relevance 
to clinicians and features 
case presentations by 
experts in the field, syn-
thesis of new data, and 
an opportunity to engage 
with colleagues during 
Q&A and discussion.
CDC/IDSA COVID-19 Clinician Calls and Media Briefings: https://www.idsociety.org/multimedia/  
SHEA Weekly Town Halls  
https://emergency.cdc.gov/coca/calls/index.asp
Podcasts Time intensive; must have 
ongoing content, with en-
gaging hosts/guests
This Podcast Will Kill You (hosted by epidemiologists Drs. Erin Welsh and Erin Allmann Updyke) https://
thispodcastwillkillyou.com/  
IDSA COVID-19 podcast https://www.idsociety.org/multimedia/  




for linking information to 
guideline, publications 
IDSA COVID-19 Real-Time Learning Network: https://www.idsociety.org/covid-19-real-time-learning-network/  
SIDP COVID-19 Resources: https://www.sidp.org/covid19  




Pre-publication peer review, 
early dissemination of 
research







Emory University Weekly COVID-19 Literature Round-Up https://scholarblogs.emory.edu/covid19roundup/
visual-abstracts/
Guidelines Issued by expert panels 
for organization that 
streamline processes 




Apps Quick access to guidelines 
and focused information 
Sanford Guide Johns Hopkins Guide  
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[7–10] and (2) expanding public aware-
ness of antimicrobial resistance among 
the general global community. Findings 
of scientific conferences are posted and 
summarized in real time to a broad on-
line audience, potentially leading to faster 
implementation of science and further 
mentorship, networking, and innovative 
collaboration through digital engage-
ment [11, 12].
For researchers and authors, 
crowdsourcing and digital dissemina-
tion can lead to greater impact [13–17]. 
Since early 2020, biomedical literature 
on COVID-19 has matured rapidly, with 
an unprecedented number of scholarly 
articles [18]. Scientists and clinicians 
are inundated with new publications; 
journal editors have been overwhelmed 
by submissions, and there is a desperate 
need to balance scientific rigor with rapid 
dissemination of results [19]. The pre-
print platforms BioRxiv and MedRxiv 
have noted an unparalleled number of 
preprints, creating challenges in parsing 
data [18]. Digital and social media can 
help to address this. For example, a team 
of immunologists at the Icahn School of 
Medicine at Mount Sinai in New York 
created a concerted effort to critically 
review preprints to improve the rigor of 
literature evaluation for consumption by 
the scientific community [20]. Another 
example of real-time, postpublication 
peer review comes from the description 
of Dr. Elisabeth Bik [21] regarding the 
rapid publication of Gautret [22] et  al 
describing the role of hydroxychloroquine 
in the treatment of COVID-19. Another 
commonly cited benefit of social media 
includes flattening of healthcare hier-
archies, fostering collaborations between 
institutions and among individuals of all 
stages of training, which is particularly 
relevant in a year when in-person meet-
ings have been curtailed [23, 24]. This 
is especially true for trainees and young 
faculty who may be parents of young 
children who face time, financial, and 
other barriers to traditional networking 
opportunities. Online journal clubs, led by 
authors and field experts (eg, @IDJClub, 
@ASP_Chat), exemplify this; their or-
ganization around central hashtags and 
published articles and open access allows 
for robust discussion and postpublication 
peer-review of critical studies in the field 
among multiple participants.
PITFALLS OF USING SOCIAL 
MEDIA FOR DIGITAL STRATEGY
Despite its many advantages, the use of 
digital platforms in medicine poses dis-
tinct challenges. The rapid dissemina-
tion of information that is not carefully 
reviewed or amplification of unverified 
sources can lead to misinformation. 
Furthermore, scientists may face online 
harassment when engaging with social 
media [25]. To be a source of trusted in-
formation, they may reveal their identity, 
credentials, and workplace information. 
This may allow critics to more easily 
target clinical experts with opposing 
views while maintaining anonymity. In 
Rapid development and
dissemination of  guidelines
IDSA COVID-19 DIGITAL STRATEGY RESPONSE
IDSA COVID-19 DIGITAL STRATEGY INVESTMENT
Website re-design with user-
friendly interface
Development of  COVID-19
podcast














Science speaks blog posts
Figure 1. IDSA COVID-19 Digital Strategy Response and Investment. The top panel shows 8 types of strategy used by Infectious Diseases Society of America (IDSA) to 
rapidly disseminate information during coronavirus disease 2019 (COVID-19). They include the following: rapid development and dissemination of guidelines for use by clin-
icians navigating the rapidly evolving paradigms of diagnosis, treatment, and infection prevention, redesign of the organization website with a more user-friendly interface, 
development of a COVID-19 twice-weekly podcast, weekly clinician press calls, weekly COVID-19 update newsletters, social media posts, infographics and visual abstracts, 
and Science Speaks blog posts. The bottom panel presents the facets of investment required to use this response including increased time commitment, increased person-
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addition, with shifting data availability, 
ID specialists with evolving views in re-
sponse to emerging data during the pan-
demic may subsequently be criticized on 
social media for changing opinions. In a 
hypothetical example, a healthcare pro-
fessional using social media to advocate 
for social distancing in areas with high 
rates of COVID-19 transmission might 
elicit backlash if that same individual had 
previously cast doubt on wearing masks 
in the early days of the COVID-19 pan-
demic. Disseminating thoughtful com-
mentary to the general public requires 
that infectious diseases (ID) specialists 
acknowledge uncertainties inherent to 
our incomplete and evolving under-
standing infections and be transparent 
that expert opinion-based recommenda-
tions may change with new data.
The “infodemic” itself proves problem-
atic for experts despite the benefit of rapid 
information dissemination. Although 
peer-review remains a cornerstone of aca-
demic publication, digital media does not 
require the same type of rigor. As a result, 
content that is shared by self-proclaimed 
subject matter experts may not undergo 
appropriate vetting before dissemination, 
potentially contributing to the circula-
tion of misinformation. It is unfortunate 
that this type of misinformation is an 
increasing concern given the ability of 
digital media to widely disseminate in-
formation at a rapid pace [26]. Moreover, 
although rapidly evolving knowledge 
during a pandemic may be expected by 
healthcare professionals to shift guide-
lines in response to new data, this may 
engender doubt and mistrust on the part 
of the general public. The combination of 
misinformation and massive information 
overload (“fire-hose” effect) disseminated 
via social media and ubiquitous preprint 
servers during COVID-19 emphasize the 
need to curate a trusted network of col-
leagues and sources on digital media and 
to temper the mental fatigue associated 
with combatting misinformation [27, 28].
RECOMMENDATIONS FOR USE OF 
DIGITAL STRATEGY TO ADVANCE 
THE FIELD OF INFECTIOUS 
DISEASES
Now, more than ever, ID specialists must 
reach patients and communities where 
they are. The ID specialists using social 
media should include, as part of their 
digital strategy, a mission to (1) build and 
preserve public trust in the profession, (2) 
curate content to engage a defined audi-
ence with aligned mission, and (3) high-
light the value of the field of infectious 
diseases, as described in Table 2, which 
includes examples of effective communi-
cation. Building and preserving the public 
trust does not mean that professional and 
personal identities must be siloed across 
accounts. One of the strengths of social 
media is that sharing content intention-
ally can humanize professionals and 
engender familiarity and trust among 
followers when done judiciously. The ID 
specialists should avoid spreading misin-
formation by independently verifying the 
accuracy of all statements shared.
Often those who are new to social 
media may engage more passively by 
observing posting without posting their 
own content. This practice, known as 
“lurking,” can be useful for a social media 
neophyte in learning the initial value of 
social media, learning online etiquette, 
and best practices for creating and com-
municating content specific to a given so-
cial media platform. Once an individual 
is ready to engage in posting and curating 
social media content professionally, indi-
viduals should ask (1) “who am I  trying 
to reach?” and (2) “what am I  trying to 
convince them to believe or do?” These 
questions will focus strategic efforts on 
content that adds value. Once a target au-
dience is identified (eg, other ID special-
ists, medical trainees, the general public), 
focus on interacting with and attracting 
followers from those communities. 
Similarly, individuals should curate the 
content being shared to inform and influ-
ence followers towards the specified goals 
originally outlined. Content curation 
means ensuring the content shared or 
interacted with (eg, “likes,” “retweets,” or 
comments) aligns with the mission of an 
individual’s digital presence, and that the 
balance between content that informs, 
persuades, and delights is appropriate 
for the targeted audience. For example, if 
the goal is to influence ID fellowship pro-
gram directors to reconsider admissions 
criteria, a Twitter Feed that is mostly 
heated arguments with antivaccination 
campaigners and photos of dogs is not 
aligned with the specific audience or 
goals. Table 2 summarizes effective an in-
effective ways to engage with social media 
as they align with the 3 main goals for so-
cial media use: build and preserve public 
trust in the profession, curate content to 
engage a defined audience with aligned 
mission, and highlight the value of the 
field of infectious diseases. Many of these 
recommendations are applicable to both 
Table 2. Recommendations for Effective Communication to Advance the Field of Infectious Diseases
Recommendations Examples 
Build and preserve public trust in the profession - Posting links to articles that demonstrate important accomplishments of public health officials
Curate content to engage a defined audience with 
aligned mission
- Amplifying messages by field experts on the role of mitigation of coronavirus disease 2019 
(COVID-19) infection risk  
- Posting articles and guidelines that instruct the public in best practices in infection prevention
Highlight the value of the field of infectious dis-
eases
- Posting an article demonstrating the impact of Infectious Diseases physicians in improving 
patient outcomes  
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individuals and organization, and the ul-
timate direction depends on the mission 
of said individual and/or organization.
As social media becomes more part of 
scientific and medical communications, 
more data will be needed to understand 
how metrics track with outcomes. Some 
have reported on how social media en-
gagement can be leverages for scholarship 
in assessing academic accomplishments 
[17, 29]. Many websites and social media 
platforms measure traffic and engage-
ment, and this information can be used 
to quantify effective and ineffective 
approaches.
CONCLUSIONS
ID specialists who use social media are 
encouraged to include bolstering sup-
port for the specialty as a primary goal. 
The ability to recruit and retain future 
generations of ID experts is dependent 
on successfully arguing for compensa-
tion appropriate for the value ID spe-
cialists bring to patients’ care. From 
multidrug-resistant nosocomial patho-
gens to emerging pathogens and global 
pandemics, ID expertise is essential for 
our communities’ survival and wellbeing. 
From individual to organizational digital 
strategy and social media engagement, 
ensuring that other health professionals 
and the general public recognize the im-
portance of this work will help ensure 
that our specialty is fairly recompensed 
and can attract future talent.
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